Insights from HuR biology point to potential improvement for second-line ovarian cancer therapy.

Oncotarget · 2016 · PMC5008325 · PMID 26943573

Europe PMC DOI

hedged sentence

0.0660

closest p · 1.3× alpha

0.0660

boldest claim

The sentences

approached significancep=0.066so close (0.05 < p ≤ 0.1)

We note, however, a correlation of lower tumor grades (Grades I and II) with low cytoplasmic HuR, and Grade III tumors with high cytoplasmic HuR approached significance (p=0.066) (Figure S1 ).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.